Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Micklem

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Biotechnology|February 22, 2008
RNAi screening for therapeutic targets in human malignanciesDavid R Micklem, James B Lorens
Expert Opinion on Drug Discovery|March 15, 2013
Drug target discovery using retrovirusesMagnus Blø, David R Micklem, James B Lorens
BMC Biotechnology|February 27, 2008
Enhanced gene expression from retroviral vectorsMagnus Blø, David R Micklem, James B Lorens
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 17, 2009
A novel imaging-based high-throughput screening approach to anti-angiogenic drug discoveryLasse Evensen, David R Micklem, Wolfgang Link, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
MicroRNAs in tumorigenesisKai Ove Skaftnesmo, Lars Prestegarden, David R Micklem, et al.
DNA and Cell Biology|September 11, 2007
Expanding the spectrum of genetic elements transferable by retroviral vectorsMagnus Blø, Jakob M Bogenberger, Susan E Swift, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 27, 2015
Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African womenLavina Ahmed, Hawa Nalwoga, Jarle B Arnes, et al.
Frontiers in Immunology|September 6, 2024
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapyAustin Rayford, Fabian Gärtner, Maria P Ramnefjell, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Plos One|June 5, 2009
Mural cell associated VEGF is required for organotypic vessel formationLasse Evensen, David R Micklem, Anna Blois, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|February 22, 2008
RNAi screening for therapeutic targets in human malignanciesDavid R Micklem, James B Lorens
Expert Opinion on Drug Discovery|March 15, 2013
Drug target discovery using retrovirusesMagnus Blø, David R Micklem, James B Lorens
BMC Biotechnology|February 27, 2008
Enhanced gene expression from retroviral vectorsMagnus Blø, David R Micklem, James B Lorens
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 17, 2009
A novel imaging-based high-throughput screening approach to anti-angiogenic drug discoveryLasse Evensen, David R Micklem, Wolfgang Link, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
MicroRNAs in tumorigenesisKai Ove Skaftnesmo, Lars Prestegarden, David R Micklem, et al.
DNA and Cell Biology|September 11, 2007
Expanding the spectrum of genetic elements transferable by retroviral vectorsMagnus Blø, Jakob M Bogenberger, Susan E Swift, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 27, 2015
Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African womenLavina Ahmed, Hawa Nalwoga, Jarle B Arnes, et al.
Frontiers in Immunology|September 6, 2024
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapyAustin Rayford, Fabian Gärtner, Maria P Ramnefjell, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Plos One|June 5, 2009
Mural cell associated VEGF is required for organotypic vessel formationLasse Evensen, David R Micklem, Anna Blois, et al.
Pageof 2